Nuveen Asset Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.26 - $6.51 $556,914 - $851,058	-130,731 Reduced 75.63%	42,118 $220,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $139,580 - $458,535	30,147 Added 21.13%	172,849 $904,000
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $1.16 Million - $1.75 Million	76,565 Added 115.77%	142,702 $2.25 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $437,911 - $786,710	-24,685 Reduced 27.18%	66,137 $1.29 Million
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $323,023 - $439,420	12,890 Added 16.54%	90,822 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $325,064 - $517,527	13,013 Added 20.04%	77,932 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $78,625 - $140,229	-2,976 Reduced 4.38%	64,919 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $1.07 Million - $1.33 Million	25,859 Added 61.52%	67,895 $3.02 Million
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $18,456 - $21,776	414 Added 0.99%	42,036 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $276,111 - $342,879	-6,026 Reduced 12.65%	41,622 $1.91 Million
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $40,987 - $52,210	-936 Reduced 1.93%	47,648 $2.66 Million
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $153,300 - $185,075	-4,159 Reduced 7.89%	48,584 $2.08 Million
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $51,085 - $64,578	1,267 Added 2.46%	52,743 $2.2 Million
Q4 2020 May 17, 2021	SELL	$41.72 - $51.34 $304,764 - $375,038	-7,305 Reduced 12.43%	51,476 $2.4 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $379,652 - $467,194	9,100 Added 18.32%	58,781 $2.74 Million
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $33,725 - $46,716	-911 Reduced 1.8%	49,681 $2.11 Million
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $271,374 - $345,305	6,276 Added 14.16%	50,592 $2.43 Million
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $38,185 - $66,737	1,111 Added 2.57%	44,316 $2.04 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $28,952 - $34,277	-533 Reduced 1.22%	43,205 $2.6 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $17,572 - $19,793	-330 Reduced 0.75%	43,738 $2.47 Million
Q2 2019 Aug 15, 2019	BUY	$46.61 - $58.45 $2.05 Million - $2.58 Million	44,068 New	44,068 $2.45 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

9.89M

Call Options Held

1.01M

Put Options Held

Nantahala Capital Management, LLC New Canaan, CT

1.96M
Shares

$4.2 Million
0.73% of portfolio
Aigh Capital Management LLC Baltimore, MD

1.21M
Shares

$2.59 Million
2.46% of portfolio
Citigroup Inc

1M
Shares

$2.14 Million
0.0% of portfolio
Aqr Capital Management LLC Greenwich, CT

697K
Shares

$1.49 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

564K
Shares

$1.21 Million
0.0% of portfolio

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $27.9M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account